Published in Biochem J on December 01, 1991
Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes (2010) 1.65
Binding of the streptococcal surface glycoproteins GspB and Hsa to human salivary proteins. Infect Immun (2006) 1.40
Salivary receptors for recombinant fimbrillin of Porphyromonas gingivalis. Infect Immun (1994) 1.36
Structural domains of Porphyromonas gingivalis recombinant fimbrillin that mediate binding to salivary proline-rich protein and statherin. Infect Immun (1996) 1.18
Human submandibular-sublingual saliva promotes adhesion of Candida albicans to polymethylmethacrylate. Infect Immun (1993) 1.16
Binding sites of salivary statherin for Porphyromonas gingivalis recombinant fimbrillin. Infect Immun (1996) 1.12
Human tracheobronchial mucin: purification and binding to Pseudomonas aeruginosa. Infect Immun (1992) 1.10
Binding of Porphyromonas gingivalis fimbriae to proline-rich glycoproteins in parotid saliva via a domain shared by major salivary components. Infect Immun (1998) 1.08
Analysis of Candida albicans adhesion to salivary mucin. Infect Immun (1993) 1.06
Macromolecular organization of saliva: identification of 'insoluble' MUC5B assemblies and non-mucin proteins in the gel phase. Biochem J (2000) 1.03
Role of the carboxyl-terminal region of Porphyromonas gingivalis fimbrillin in binding to salivary proteins. Infect Immun (1997) 0.98
Active sites of salivary proline-rich protein for binding to Porphyromonas gingivalis fimbriae. Infect Immun (1997) 0.97
Isolation and physical characterization of the MUC7 (MG2) mucin from saliva: evidence for self-association. Biochem J (1998) 0.96
Confident assignment of intact mass tags to human salivary cystatins using top-down Fourier-transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom (2010) 0.94
Identification of salivary mucin MUC7 binding proteins from Streptococcus gordonii. BMC Microbiol (2009) 0.88
Oral streptococci utilize a Siglec-like domain of serine-rich repeat adhesins to preferentially target platelet sialoglycans in human blood. PLoS Pathog (2014) 0.87
Inhibition of Porphyromonas gingivalis adhesion to Streptococcus gordonii by human submandibular-sublingual saliva. Infect Immun (1992) 0.87
Structural features of the human salivary mucin, MUC7. Glycoconj J (1998) 0.86
Structural features of the low-molecular-mass human salivary mucin. Biochem J (1992) 0.83
Mucin levels in saliva of adolescents with dental caries. Med Sci Monit (2014) 0.80
Tyrosine sulfation of statherin. Int J Biol Sci (2007) 0.79
Absence of capsule reveals glycan-mediated binding and recognition of salivary mucin MUC7 by Streptococcus pneumoniae. Mol Oral Microbiol (2015) 0.77
An unusual glycoform of human salivary mucin MG2. Clin Oral Investig (2011) 0.76
Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus? Virol J (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem (1981) 71.15
The thiobarbituric acid assay of sialic acids. J Biol Chem (1959) 43.78
DISC ELECTROPHORESIS. I. BACKGROUND AND THEORY. Ann N Y Acad Sci (1964) 26.94
Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol (1981) 6.84
Complete amino acid analysis of proteins from a single hydrolysate. J Biol Chem (1976) 5.58
Labeling of proteins by reductive methylation using sodium cyanoborohydride. J Biol Chem (1979) 5.42
Specificity of salivary-bacterial interactions: role of terminal sialic acid residues in the interaction of salivary glycoproteins with Streptococcus sanguis and Streptococcus mutans. Infect Immun (1978) 3.12
Specificity of salivary-bacterial interactions: II. Evidence for a lectin on Streptococcus sanguis with specificity for a NeuAc alpha 2, 3Ga1 beta 1, 3Ga1NAc sequence. Biochem Biophys Res Commun (1982) 2.81
Human salivary acidic proline-rich proteins and statherin promote the attachment of Actinomyces viscosus LY7 to apatitic surfaces. Infect Immun (1988) 1.91
Complete covalent structure of statherin, a tyrosine-rich acidic peptide which inhibits calcium phosphate precipitation from human parotid saliva. J Biol Chem (1977) 1.89
Adherence of Streptococcus sanguis to saliva-coated hydroxyapatite: evidence for two binding sites. Infect Immun (1984) 1.86
The complete amino-acid sequence of hen ovalbumin. Eur J Biochem (1981) 1.66
Characterization of salivary alpha-amylase binding to Streptococcus sanguis. Infect Immun (1989) 1.60
Adherence of Streptococcus sanguis to salivary mucin bound to glass. J Dent Res (1982) 1.44
The primary structure of a salivary calcium-binding proline-rich phosphoprotein (protein C), a possible precursor of a related salivary protein A. J Biol Chem (1980) 1.42
The binding of human salivary alpha-amylase by oral strains of streptococcal bacteria. Arch Oral Biol (1983) 1.42
Characterization of in vivo salivary-derived enamel pellicle. Arch Oral Biol (1989) 1.40
Purification of a low-molecular-weight, mucin-type glycoprotein from human submandibular-sublingual saliva. Carbohydr Res (1982) 1.31
Biochemical and biophysical comparison of two mucins from human submandibular-sublingual saliva. Arch Biochem Biophys (1987) 1.30
The primary structures of six human salivary acidic proline-rich proteins (PRP-1, PRP-2, PRP-3, PRP-4, PIF-s and PIF-f). Biochem J (1988) 1.25
The role of human salivary acidic proline-rich proteins in the formation of acquired dental pellicle in vivo and their fate after adsorption to the human enamel surface. Arch Oral Biol (1983) 1.24
Association of neuraminidase-sensitive receptors and putative hydrophobic interactions with high-affinity binding sites for Streptococcus sanguis C5 in salivary pellicles. Infect Immun (1983) 1.24
Inhibition of Neisseria gonorrhoeae by normal human saliva. Br J Vener Dis (1979) 1.23
Immunochemical identification and determination of proline-rich proteins in salivary secretions, enamel pellicle, and glandular tissue specimens. J Dent Res (1980) 1.14
Chemical and physical characterization of a phosphoprotein, Protein C, from human saliva and comparison with a related protein A. Biochem J (1977) 1.12
Adsorption thermodynamics of acidic proline-rich human salivary proteins onto calcium apatites. J Biol Chem (1982) 1.12
Properties of cysteine-containing phosphoproteins from human submandibular-sublingual saliva. J Dent Res (1982) 1.09
Preparation of a sialic acid-binding protein from Streptococcus mitis KS32AR. Infect Immun (1986) 1.04
Human cysteine-proteinase inhibitors: nucleotide sequence analysis of three members of the cystatin gene family. Gene (1987) 1.03
Immunochemistry and immunogenicity of low molecular weight human salivary mucin. Arch Oral Biol (1991) 1.02
Structural relationship between the enzymatic and streptococcal binding sites of human salivary alpha-amylase. Biochem Biophys Res Commun (1990) 1.01
The amino acid sequence of a salivary proline-rich peptide, P-C, and its relation to a salivary proline-rich phosphoprotein, protein C. J Biochem (1980) 1.01
Complete covalent structure of a proline-rich phosphoprotein, PRP-2, an inhibitor of calcium phosphate crystal growth from human parotid saliva. Int J Pept Protein Res (1986) 0.99
Genetics of human salivary proteins. J Dent Res (1989) 0.98
Purification, molecular cloning, and sequencing of salivary cystatin SA-1. J Biol Chem (1988) 0.98
Isolation and amino acid sequence of SAP-1, an acidic protein of human whole saliva, and sequence homology with human gamma-trace. J Biochem (1984) 0.97
Characterization of hen egg white- and yolk-riboflavin binding proteins and amino acid sequence of egg white-riboflavin binding protein. J Biochem (1984) 0.92
Masticatory lubrication. The role of carbohydrate in the lubricating property of a salivary glycoprotein-albumin complex. Biochem J (1985) 0.92
Cystatin S: a cysteine proteinase inhibitor of human saliva. J Biochem (1984) 0.90
Characterization and amino acid sequence of a new acidic cysteine proteinase inhibitor (cystatin SA) structurally closely related to cystatin S, from human whole saliva. J Biochem (1987) 0.90
Sequences of sixteen phosphoserine peptides from ovalbumins of eight species. Eur J Biochem (1981) 0.89
Artificial salivas: present and future. J Dent Res (1987) 0.88
Phosphorus-31 nuclear magnetic resonance studies of the two phosphoserine residues of hen egg white ovalbumin. Biochemistry (1982) 0.87
Primary structure and possible origin of the non-glycosylated basic proline-rich protein of human submandibular/sublingual saliva. Biochem J (1989) 0.87
Multiple forms of statherin in human salivary secretions. Arch Oral Biol (1991) 0.86
The isolation of a family of cysteine-containing phosphoproteins from human submandibular-sublingual saliva. J Dent Res (1982) 0.86
The cysteine proteinase inhibitor chicken cystatin is a phosphoprotein. FEBS Lett (1989) 0.86
External radiolabelling of components of pellicle on human enamel and cementum. Arch Oral Biol (1987) 0.82
Isolation and amino acid sequences of proline-rich peptides of human whole saliva. J Biochem (1979) 0.82
Quantitative determination of phosphoserine by high-performance liquid chromatography as the phenylthiocarbamyl-S-ethylcysteine. Application to picomolar amounts of peptides and proteins. J Chromatogr (1987) 0.81
Identification of a long form of cystatin from human saliva by rapid microbore HPLC mapping. Biochem Biophys Res Commun (1987) 0.80
In vitro characterization of human salivary lubrication. Arch Oral Biol (1989) 0.80
Characterization of cysteine-containing phosphoproteins from human submandibular-sublingual saliva. J Dent Res (1982) 0.80
Cystatin superfamily. Evidence that family II cystatin genes are evolutionarily related to family III cystatin genes. Biol Chem Hoppe Seyler (1988) 0.78
Lubrication of selected salivary molecules and artificial salivas. Dysphagia (1989) 0.78
A new assessment in vitro of human salivary lubrication using a compliant substrate. Arch Oral Biol (1990) 0.77
Immunological cross-reactivity of anionic proteins from caries-free and caries-active salivas which differ in biological properties toward oral streptococci. Infect Immun (1986) 0.77
Specificity of salivary-bacterial interactions: role of terminal sialic acid residues in the interaction of salivary glycoproteins with Streptococcus sanguis and Streptococcus mutans. Infect Immun (1978) 3.12
Periodontal infection and preterm birth: results of a prospective study. J Am Dent Assoc (2001) 2.94
Specificity of salivary-bacterial interactions: II. Evidence for a lectin on Streptococcus sanguis with specificity for a NeuAc alpha 2, 3Ga1 beta 1, 3Ga1NAc sequence. Biochem Biophys Res Commun (1982) 2.81
Role of salivary mucins in the protection of the oral cavity. J Oral Pathol (1982) 2.14
Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J Biol Chem (1993) 2.11
Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Int J Impot Res (2007) 2.07
Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect Immun (1991) 1.93
The Coventry Award. Polymerase chain reaction detection of bacterial infection in total knee arthroplasty. Clin Orthop Relat Res (1996) 1.83
Salivary histatin 5: dependence of sequence, chain length, and helical conformation for candidacidal activity. J Biol Chem (1990) 1.63
Isolation and immunochemical characterization of the group-specific antigen of Streptococcus mutants 6715. Infect Immun (1975) 1.62
Characterization of salivary alpha-amylase binding to Streptococcus sanguis. Infect Immun (1989) 1.60
Position statement and guidelines on unmodified electroconvulsive therapy. Indian J Psychiatry (2012) 1.58
Salivary alpha-amylase: role in dental plaque and caries formation. Crit Rev Oral Biol Med (1993) 1.56
Differential agar medium for separating Streptococcus lactis and Streptococcus cremoris. Appl Microbiol (1969) 1.50
Adherence of Streptococcus sanguis to salivary mucin bound to glass. J Dent Res (1982) 1.44
Structural aspects of salivary glycoproteins. J Dent Res (1987) 1.44
Binding of streptococcal antigens to muscle tissue in vitro. Infect Immun (1980) 1.42
Biological effects of a purified lipopolysaccharide from Bacteroides gingivalis. J Periodontal Res (1983) 1.42
The effect of systemic flurbiprofen on bone supporting dental implants. J Am Dent Assoc (1995) 1.41
Modulation of bone metabolism by two chemically distinct lipopolysaccharide fractions from Bacteroides gingivalis. Infect Immun (1986) 1.40
Characterization of in vivo salivary-derived enamel pellicle. Arch Oral Biol (1989) 1.40
Observation of an antimatter hypernucleus. Science (2010) 1.38
Inhibition of neutrophil chemotaxis by soluble bacterial products. J Periodontol (1982) 1.38
Salivary receptors for recombinant fimbrillin of Porphyromonas gingivalis. Infect Immun (1994) 1.36
Adherence of Porphyromonas (Bacteroides) gingivalis to Streptococcus sanguis in vitro. Infect Immun (1991) 1.33
Salivary statherin. Dependence on sequence, charge, hydrogen bonding potency, and helical conformation for adsorption to hydroxyapatite and inhibition of mineralization. J Biol Chem (1992) 1.33
Structures of N-glycosidic carbohydrate units of human chorionic gonadotropin. J Biol Chem (1979) 1.32
Purification of a low-molecular-weight, mucin-type glycoprotein from human submandibular-sublingual saliva. Carbohydr Res (1982) 1.31
Biochemical and biophysical comparison of two mucins from human submandibular-sublingual saliva. Arch Biochem Biophys (1987) 1.30
Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy. J Periodontol (1979) 1.30
A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin Periodontol (1989) 1.24
The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol (1991) 1.24
Structure of human salivary alpha-amylase at 1.6 A resolution: implications for its role in the oral cavity. Acta Crystallogr D Biol Crystallogr (1996) 1.20
Effect of anaerobiosis on the surface ultrastructure and surface proteins of Actinobacillus actinomycetemcomitans (Haemophilus actinomycetemcomitans). Infect Immun (1987) 1.16
Human submandibular-sublingual saliva promotes adhesion of Candida albicans to polymethylmethacrylate. Infect Immun (1993) 1.16
Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experience. J Am Coll Cardiol (1992) 1.15
Characterization of an amylase-binding component of Streptococcus gordonii G9B. Infect Immun (1992) 1.15
Characterization of a polysaccharide antigen from Bacteroides gingivalis. J Immunol (1989) 1.14
Formation of salivary-mucosal pellicle: the role of transglutaminase. Biochem J (1992) 1.13
The isolation from human parotid saliva and partial characterization of the protein core of a major parotid glycoprotein. Arch Oral Biol (1973) 1.13
Statherin: a major boundary lubricant of human saliva. Biochem Biophys Res Commun (1991) 1.12
Salivary amylase promotes adhesion of oral streptococci to hydroxyapatite. J Dent Res (1995) 1.12
Isolation of heart- and kidney-binding protein from group A streptococci. Infect Immun (1982) 1.10
1985 Kreshover lecture. Molecular factors influencing neutrophil defects in periodontal disease. J Dent Res (1986) 1.10
Pellicle receptors for Actinomyces viscosus type 1 fimbriae in vitro. Infect Immun (1989) 1.10
Candidacidal activity prompted by N-terminus histatin-like domain of human salivary mucin (MUC7)1. Biochim Biophys Acta (1999) 1.09
Neutrophil function and oral disease. J Oral Pathol (1985) 1.09
Management of restenosis within the Palmaz-Schatz coronary stent (the U.S. multicenter experience. The U.S. Palmaz-Schatz Stent Investigators. Am J Cardiol (1993) 1.09
Properties of cysteine-containing phosphoproteins from human submandibular-sublingual saliva. J Dent Res (1982) 1.09
Development of a novel, rapid processing protocol for polymerase chain reaction-based detection of bacterial infections in synovial fluids. Mol Biotechnol (1995) 1.07
Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol (1989) 1.06
Radiographic diagnosis in periodontics. Periodontol 2000 (1995) 1.04
Preparation of a sialic acid-binding protein from Streptococcus mitis KS32AR. Infect Immun (1986) 1.04
Glucosyltransferase mediates adhesion of Streptococcus gordonii to human endothelial cells in vitro. Infect Immun (1994) 1.04
Structure of the carbohydrate chains of the proline-rich glycoprotein from human parotid saliva. Biochem Biophys Res Commun (1982) 1.04
Biosolubilization of poorly soluble rock phosphates by Aspergillus tubingensis and Aspergillus niger. Bioresour Technol (2002) 1.03
Immune properties of glucosyltransferases from S. sobrinus. J Oral Pathol (1988) 1.03
Post-menopausal bone loss and its relationship to oral bone loss. Periodontol 2000 (2000) 1.03
The isolation and analysis of a glycoprotein from parotid saliva. Biochim Biophys Acta (1969) 1.02
Current evidence regarding periodontal disease as a risk factor in preterm birth. Ann Periodontol (2001) 1.02
Use of the photoaffinity cross-linking agent N-hydroxysuccinimidyl-4-azidosalicylic acid to characterize salivary-glycoprotein-bacterial interactions. Biochem J (1986) 1.02
Membrane-induced helical conformation of an active candidacidal fragment of salivary histatins. J Biol Chem (1994) 1.02
Hydroxyapatite binding domains in salivary proteins. Crit Rev Oral Biol Med (1993) 1.02
Immunochemistry and immunogenicity of low molecular weight human salivary mucin. Arch Oral Biol (1991) 1.02
Reduced chemotactic peptide binding in juvenile periodontitis: a model for neutrophil function. Biochem Biophys Res Commun (1981) 1.02
Saliva: a significant factor in removable prosthodontic treatment. J Prosthet Dent (1987) 1.02
Structural relationship between the enzymatic and streptococcal binding sites of human salivary alpha-amylase. Biochem Biophys Res Commun (1990) 1.01
Divergent solid-phase synthesis and candidacidal activity of MUC7 D1, a 51-residue histidine-rich N-terminal domain of human salivary mucin MUC7. J Pept Res (2000) 0.99
Genetic diversity and phylogeny of antagonistic bacteria against Phytophthora nicotianae isolated from tobacco rhizosphere. Int J Mol Sci (2011) 0.99
Purification, molecular cloning, and sequencing of salivary cystatin SA-1. J Biol Chem (1988) 0.98
Effect of glucagon infusion on cardiovascular function in critically ill surgical patients. Surg Forum (1969) 0.98
Role of the carboxyl-terminal region of Porphyromonas gingivalis fimbrillin in binding to salivary proteins. Infect Immun (1997) 0.98
A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodontol (1995) 0.97
Rhizobacteria-Mediated Growth Promotion of Tomato Leads to Protection Against Cucumber mosaic virus. Phytopathology (2003) 0.97
Immunochemical quantitation of alpha-amylase and secretory IgA in parotid saliva from people of various ages. Arch Oral Biol (1987) 0.97
A two-strain mixture of rhizobacteria elicits induction of systemic resistance against Pseudomonas syringae and Cucumber mosaic virus coupled to promotion of plant growth on Arabidopsis thaliana. J Microbiol Biotechnol (2007) 0.96
Interaction of HIV-1 and human salivary mucins. J Acquir Immune Defic Syndr (1994) 0.96
Delineation of conformational preferences in human salivary statherin by 1H, 31P NMR and CD studies: sequential assignment and structure-function correlations. J Biomol Struct Dyn (1998) 0.96
Lactose mother liquor as an alternative nutrient source for microbial concrete production by Sporosarcina pasteurii. J Ind Microbiol Biotechnol (2008) 0.95